Lapatinib Completed Phase 2 Trials for Neoplasms, Brain / Spinal Cord Tumors Treatment

Back to Lapatinib
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00826241Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma